Research sites are at the heart of clinical research 

At Novotech, we believe successful studies begin with meaningful collaboration. We work alongside investigators and research teams with clear communication, respect for site expertise, and responsive operational support, from study planning through study delivery.

How we work with sites

By engaging sites early to understand real-world considerations before key study decisions are finalized, we help ensure protocol feasibility and sustainable trial design. This supports a more efficient experience for research teams while supporting high-quality study delivery.

Studies succeed when sites succeed

We see site success as an early indicator of overall trial success. By listening to site feedback, incorporating operational insights, and focusing on what sites need to perform at their best, together we create more efficient and effective clinical trials.

What sites can expect of Novotech

  • Site insights inform decisions

    We actively seek site feedback and incorporate operational perspectives into study planning, feasibility, startup, and execution.

  • Reducing site burden

    We look for opportunities to simplify processes, minimize administrative burden, and make participation easier for site teams.

  • Relationships beyond a single study

    We invest in long-term relationships with research sites, creating continuity, trust, and deeper understanding over time.

  • Operationally grounded execution

    Our approach is informed by the realities of site operations, helping bridge the gap between study design and study delivery.

Why Novotech?

  • From local insight to global development

    Access opportunities across a global portfolio while working with teams who understand local healthcare systems, regulatory requirements, and site realities.

  • Support for biotech and emerging pharma

    We support biotech and small to mid-sized pharmaceutical companies across complex clinical development programs, bringing the experience and agility needed to navigate fast-moving development environments.

  • Experienced study teams

    Our clinical, medical, and operational teams bring deep clinical development expertise and work together to support quality study execution.

Broad therapeutic expertise

Studies conducted and sites activated globally across our core therapeutic areas.

  • Oncology

    850+ Studies conducted
    3,475 Sites activated globally
  • Immunology

    500+ Studies conducted
    1,364 Sites activated globally
  • Infectious diseases

    400+ Studies conducted
    1,499 Sites activated globally
  • Central nervous system

    265+ Studies conducted
    370+ Sites activated globally

Studies by phase

1,023

378
253
268
124

601

306
120
98
77

357

137
109
55
56

79

30
27
12
10
 
Phase I Phase II Phase III Phase IV
 Oncology
 Immunology
 Infectious diseases
 Central nervous system

Dedicated Site Engagement and Feasibility Expertise

Our site specialists bring clinical research and operational experience to work closely with sites, support study start-up and delivery, and help navigate clinical trial requirements across regions and phases.

Julie Wilhjelm

Julie Wilhjelm Head of North America Site Strategy and Engagement

Julie Gargano Senior Director Site Engagement and Feasibility, ANZ